Acta Microbiologica et Immunologica Hungarica
Volume/Issue:
Volume 72: Issue 1
Genotypic analysis and biofilm formation of Acinetobacter baumannii clinical isolates
Authors:
Fatma Zehra Duymaz Necip Fazıl City Hospital, Medical Microbiology, Kahramanmaras, Turkey

Search for other papers by Fatma Zehra Duymaz in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0002-7433-7285
,
Fatma Budak Medical Microbiology Department, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey

Search for other papers by Fatma Budak in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0001-8439-3881
, and
Elif Okumuş Van Training and Research Hospital, Medical Microbiology, Van, Turkey

Search for other papers by Elif Okumuş in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0003-2191-6651
Pages:
33–38
Online Publication Date:
24 Mar 2025
Publication Date:
27 Mar 2025
Article Category:
Research Article
DOI:
https://doi.org/10.1556/030.2025.02531
Keywords:
A. baumannii ST2 clone; csuE; MDR
Restricted access

Abstract

Acinetobacter baumannii is a significant nosocomial pathogen recognized for its multidrug-resistance (MDR) and capacity to endure in hospital settings. This study aims to investigate the clonal relationships of A. baumannii isolates from diverse clinical samples, identify the sequence types of MDR isolates, and examine biofilm formation activity and biofilm-associated genes that contribute to persistence in hospital settings. A total of 90 A. baumannii isolates were analyzed. Bacterial identification and antibiotic susceptibility testing were conducted with MALDI-TOF MS and Vitek-2. REP-PCR was utilized to evaluate clonal connections, MLST was employed for specific isolates. Biofilm formation activity was assessed using the XTT reduction assay, and biofilm-associated genes were identified by PCR. REP-PCR revealed 29 genotypes, with Genotype A being identified as the endemic clone in 59% of isolates. Two isolates representing this genotype were found to belong to the ST2 clone. The majority of A. baumannii isolates possess biofilm-related genes and exhibit strong biofilm activity. In MDR isolates, ompA and csuE positivity were significantly higher than those non-MDR isolates (P = 0.003, P = 0.001). The csuE positive isolates were found to have significantly stronger biofilm activity than negative ones (P = 0.009). This study emphasizes the prevalence of a hospital-endemic, MDR A. baumannii genotype A, ST2 clone, and the genetic variability across isolates. No direct correlation was noted between MDR status and biofilm formation; however, some biofilm-related genes, notably csuE, were linked to stronger biofilm activity. These findings underscore the necessity for ongoing molecular surveillance and infection control measures to avert the dissemination of MDR A. baumannii in healthcare environments.

  • 1.

    Duarte DFB, Rodrigues G. Acinetobacter baumannii: insights towards a comprehensive approach for the prevention of outbreaks in health‐care facilities. APMIS 2022; 130: 330–337.

    • Search Google Scholar
    • Export Citation
  • 2.

    Almasaudi SB. Acinetobacter spp. as nosocomial pathogens: epidemiology and resistance features. Saudi J Biol Sci 2018; 25: 586–596.

  • 3.

    Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538–582.

  • 4.

    Vázquez-López R, Solano-Gálvez S, Vignon-Whaley JJJ, Vaamonde JA, Alonzo LAP, Reséndiz AR, et al. Acinetobacter baumannii resistance: a real challenge for clinicians. Antibiotics 2020; 9.

    • Search Google Scholar
    • Export Citation
  • 5.

    Liu Q, Li W, Du X, Li W, Zhong T, Tang Y, et al. Risk and prognostic factors for multidrug-resistant acinetobacter baumannii complex bacteremia: a retrospective study in a tertiary hospital of west China. PLoS One 2015; 10.

    • Search Google Scholar
    • Export Citation
  • 6.

    Nutman A, Marchaim D. How to: molecular investigation of a hospital outbreak. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 2019; 25: 688–695.

    • Search Google Scholar
    • Export Citation
  • 7.

    Forde B, Bergh H, Cuddihy T, Hajkowicz K, Hurst T, Playford E, et al. Clinical implementation of routine whole-genome sequencing for hospital infection control of multi-drug resistant pathogens. Clin Infect Dis 2023; 76: 1277–1284.

    • Search Google Scholar
    • Export Citation
  • 8.

    Chandramohan D, Ford D, Beck E, Carroll T, O’Neil S, Cadena J. 1446. Multidrug-resistant acinetobacter baumannii complex cluster outbreak investigation. Open Forum Infect Dis 2023; 10.

    • Search Google Scholar
    • Export Citation
  • 9.

    Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol 2018; 16: 91–102.

    • Search Google Scholar
    • Export Citation
  • 10.

    Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 2009; 4: 273–278.

  • 11.

    Zarrilli R. Acinetobacter baumannii virulence determinants involved in biofilm growth and adherence to host epithelial cells. Virulence 2016; 7: 367–3688.

    • Search Google Scholar
    • Export Citation
  • 12.

    Jadhav A, Shaikh N. Multidrug-resistant acinetobacter. Int J Curr Microbiol Appl Sci 2017; 6: 1598–1603.

  • 13.

    Ahmad N, Mohammad G. Identification of acinetobacter baumannii and determination of MDR and XDR strains. Baghdad Sci J 2020; 17.

  • 14.

    Bou G, Cerveró G, Domínguez MA, Quereda C, Martínez-Beltrán J. PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 2000; 6: 635–643.

    • Search Google Scholar
    • Export Citation
  • 15.

    Luo TL, Rickard AH, Srinivasan U, Kaye KS, Foxman B. Association of blaOXA-23 and bap with the persistence of Acinetobacter baumannii within a major healthcare system. Front Microbiol 2015; 6: 182.

    • Search Google Scholar
    • Export Citation
  • 16.

    Tomaras AP, Flagler MJ, Dorsey CW, Gaddy JA, Actis LA. Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology 2008; 154: 3398–3409.

    • Search Google Scholar
    • Export Citation
  • 17.

    Sung JY, Koo SH, Kim S, Kwon GC. Persistence of multidrug-resistant acinetobacter baumannii isolates harboring blaOXA-23 and bap for 5 years. J Microbiol Biotechnol 2016; 26: 1481–1489.

    • Search Google Scholar
    • Export Citation
  • 18.

    Azizi O, Shahcheraghi F, Salimizand H, Modarresi F, Shakibaie MR, Mansouri S, et al. Molecular analysis and expression of bap gene in biofilm-forming multi-drug-resistant acinetobacter baumannii. Rep Biochem Mol Biol 2016; 5: 62–72.

    • Search Google Scholar
    • Export Citation
  • 19.

    Modarresi F, Azizi O, Shakibaie MR, Motamedifar M, Valibeigi B, Mansouri S. Effect of iron on expression of efflux pump (adeABC) and quorum sensing (luxI, luxR) genes in clinical isolates of Acinetobacter baumannii. APMIS 2015; 123: 959–968.

    • Search Google Scholar
    • Export Citation
  • 20.

    Dorsey CW, Tomaras AP, Actis LA. Genetic and phenotypic analysis of Acinetobacter baumannii insertion derivatives generated with a transposome system. Appl Environ Microbiol 2002; 68: 6353–6360.

    • Search Google Scholar
    • Export Citation
  • 21.

    Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 2010; 5: e10034.

    • Search Google Scholar
    • Export Citation
  • 22.

    Mohammed S, Noaman A, Jalil IS. Epidemiological review of nosocomial infections caused by Acinetobacter baumanni. Sci Arch 2022; 3: 80–83.

    • Search Google Scholar
    • Export Citation
  • 23.

    Shrestha S, Tada T, Miyoshi-Akiyama T, Ohara H, Shimada K, Satou K, et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage. Int J Antimicrob Agents 2015; 46(5): 526–531.

    • Search Google Scholar
    • Export Citation
  • 24.

    Carvalho K, Carvalho-Assef A, Peirano G, Santos LCG Dos, Pereira MJF, Asensi M. Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying bla(OXA-23) collected from hospitals in Rio de Janeiro, Brazil. Int J Antimicrob Agents 2009; 34(1): 25–28.

    • Search Google Scholar
    • Export Citation
  • 25.

    Salehi B, Goudarzi H, Nikmanesh B, Houri H, Alavi-Moghaddam M, Ghalavand Z. Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran. J Infect Chemother 2018; 24(7): 515–523.

    • Search Google Scholar
    • Export Citation
  • 26.

    Badave GK, Kulkarni D. Biofilm producing multidrug resistant acinetobacter baumannii: an emerging challenge. J Clin Diagn Res 2015; 9: 8–10.

    • Search Google Scholar
    • Export Citation
  • 27.

    Qi L, Li H, Zhang C, Liang B, Li J, Wang L, et al. Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in acinetobacter baumannii. Front Microbiol 2016; 7: 483.

    • Search Google Scholar
    • Export Citation
  • 28.

    Zeighami H, Valadkhani F, Shapouri R, Samadi E, Haghi F. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients. BMC Infect Dis 2019; 19: 629.

    • Search Google Scholar
    • Export Citation
  • 29.

    Santajit S, Bhoopong P, Kong-Ngoen T, Tunyong W, Horpet D, Paehoh-Ele W, et al. Phenotypic and genotypic investigation of carbapenem-resistant acinetobacter baumannii in Maharaj Nakhon Si Thammarat hospital, Thailand. Antibiotics 2023; 12: 580.

    • Search Google Scholar
    • Export Citation
  • 30.

    Altınok Ö, Boral B, Ergin A, Eser ÖK. Existence of biofilm and biofilm-associated virulence genes in multi-drug resistant invasive acinetobacter baumannii isolates. Mikrobiyol Bul 2020; 54(1): 40–49.

    • Search Google Scholar
    • Export Citation
  • 31.

    Pakharukova N, Tuittila M, Paavilainen S, Malmi H, Parilova O, Teneberg S, et al. Structural basis for Acinetobacter baumannii biofilm formation. Proc Natl Acad Sci U S A. 2018; 115: 5558–5563.

    • Search Google Scholar
    • Export Citation
  • 32.

    Mammina C, Bonura C, Aléo A, Calà C, Caputo G, Cataldo MC, et al. Characterization of Acinetobacter baumannii from intensive care units and home care patients in Palermo, Italy. Clin Microbiol Infect 2011; 17: 12–15.

    • Search Google Scholar
    • Export Citation
  • 33.

    Kubo Y, Komatsu M, Tanimoto E, Sugimoto K, Tanaka S, Migita S, et al. Spread of OXA-23-producing Acinetobacter baumannii ST2 and ST246 in a hospital in Japan. J Med Microbiol 2015; 64(7): 739–744.

    • Search Google Scholar
    • Export Citation
  • 34.

    Villalón P, Valdezate S, Medina-Pascual M, Rubio V, Vindel A, Sáez-Nieto J. Clonal diversity of nosocomial epidemic acinetobacter baumannii strains isolated in Spain. J Clin Microbiol 2010; 49: 875–882.

    • Search Google Scholar
    • Export Citation
  • 35.

    Chatterjee P, Jinadatha C, Kaye K, Choi H, Allton Y, Stibich M, et al. 679. Predominance of acinetobacter baumannii sequence type 2 (ST2) among clinical isolates from two Detroit hospitals using whole genome sequencing. Open Forum Infect Dis 2020; 7.

    • Search Google Scholar
    • Export Citation
  • 36.

    Saule M, Samuelsen Ø, Dumpis U, Sundsfjord A, Karlsone A, Balode A, et al. Dissemination of a carbapenem-resistant acinetobacter baumannii strain belonging to international clone II/sequence type 2 and harboring a novel AbaR4-like resistance Island in Latvia. Antimicrob Agents Chemother 2012; 57: 1069–1072.

    • Search Google Scholar
    • Export Citation
  • 37.

    Atrouni A, Hamzé M, Jisr T, Lemarié C, Eveillard M, Joly-Guillou M, et al. Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon. Int J Infect Dis 2016; 52: 29–36.

    • Search Google Scholar
    • Export Citation
  • 38.

    El-Sayed-Ahmed MAE-G, Amin MA, Tawakol WM, Loucif L, Bakour S, Rolain J-M. High prevalence of bla(NDM-1) carbapenemase-encoding gene and 16S rRNA armA methyltransferase gene among Acinetobacter baumannii clinical Isolates in Egypt. Antimicrob Agents Chemother 2015; 59: 3602–3605.

    • Search Google Scholar
    • Export Citation
  • Collapse
  • Expand
Cover Acta Microbiologica et Immunologica Hungarica
Acta Microbiologica et Immunologica Hungarica A Quarterly of the Hungarian Academy of Sciences
Print ISSN:
1217-8950
Online ISSN:
1588-2640

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • CABELLS Journalytics
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded

2024  
Scopus  
CiteScore  
CiteScore rank  
SNIP  
Scimago  
SJR index 0.41
SJR Q rank Q3

2023  
Web of Science  
Journal Impact Factor 1.3
Rank by Impact Factor Q4 (Immunology)
Journal Citation Indicator 0.31
Scopus  
CiteScore 2.3
CiteScore rank Q3 (Infectious Diseases)
SNIP 0.389
Scimago  
SJR index 0.308
SJR Q rank Q3

Acta Microbiologica et Immunologica Hungarica
Publication Model Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article (only for OA publications)
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2025 Online subsscription: 772 EUR / 848 USD
Print + online subscription: 860 EUR / 944 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation		 1954
Volumes
per Year		 1
Issues
per Year		 4
Founder Magyar Tudományos Akadémia
Founder's
Address		 H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher		 Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Nov 2024 0 0 0
Dec 2024 0 0 0
Jan 2025 0 0 0
Feb 2025 0 0 0
Mar 2025 369 8 12
Apr 2025 217 2 4
May 2025 0 0 0